Seven West Media’s Interest in Orthocell
Seven West Media has shown a strong focus on ASX-listed medtech company Orthocell, raising curiosity about their motive. Orthocell is a Perth-based firm specializing in cell regeneration therapies.
Orthocell Overview
- Founded in 2007 as a spin-out from the University of Western Australia.
- Market capitalization fluctuates around $300 million.
- Stock price increased by about 80% in the past year.
- One of many small-scale medtech companies on the ASX.
Subscription Offer
Subscribers receive 5 free articles each month that they can share with others, highlighting Seven West Media’s outreach strategy.
Most people wouldn’t have heard of Orthocell.
Despite its modest size, Orthocell has maintained steady growth and caught media attention, particularly from Seven West Media.
Summary
Seven West Media’s keen coverage of Orthocell indicates a strategic interest in emerging medtech firms with solid growth potential on the ASX.
Author’s note: Seven West Media is uniquely amplifying smaller medtech firms like Orthocell, reflecting trends in media and market focus.